CAV1 and posterior cortical atrophy: We therefore investigated potential metabolic alterations following RT and combined dasatinib treatment in both cell types, namely LNCaP cells with low endogenous CAV1 levels and CAV1-expressing fibroblasts, resembling the initial situation of CAV1 distribution levels within early PCa (Figure 7).